SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-03-032350
Filing Date
2003-11-26
Accepted
2003-11-26 09:29:37
Documents
1
Period of Report
2003-11-25

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c81314-01shk.html 4  
1 MAIN DOCUMENT DESCRIPTION c81314-01shk.xml 4 1995
  Complete submission text file 0001209191-03-032350.txt   3908
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 210 CENTRAL PARK SOUTH NEW YORK NY 10019
KANZER STEVE H (Reporting) CIK: 0001076653 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 031024625